# India Nano Biotechnology Market > India Nano Biotechnology Market Research Report By Application (Pharmaceuticals, Medical devices, Medical research, Food and Agriculture) and By Therapeutics (Dental therapies, Cardiac therapies, Orthopedic therapies, Others) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 9.6% - **2024:** $ 244.63 Million - **2025:** $ 268.12 Million - **2035:** $ 670.68 Million - **Key Players:** Amgen Inc (US), Bayer AG (DE), Thermo Fisher Scientific Inc (US), Merck KGaA (DE), Novartis AG (CH), Pfizer Inc (US), Roche Holding AG (CH), Johnson & Johnson (US), GSK plc (GB) **Report ID:** MRFR/LS/50088-HCR · **Pages:** 200 · **Author:** Rahul Gotadki · **Last Updated:** February 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/india-nano-biotechnology-market-51846 --- ## Market Summary ## **India Nano Biotechnology Market Overview** As per MRFR analysis, the India Nano Biotechnology Market Size was estimated at 223.36 (USD Million) in 2023.The India Nano Biotechnology Market is expected to grow from 244.8(USD Million) in 2024 to 983.2 (USD Million) by 2035. The India Nano Biotechnology Market CAGR (growth rate) is expected to be around 13.473% during the forecast period (2025 - 2035). **Key India Nano Biotechnology Market Trends Highlighted** The Indian market for nanobiotechnology is expanding significantly due to a number of important factors. The growing need for personalised medicine and advanced medical therapies, which are at the forefront of research supported by both the public and private sectors, is one of the main factors propelling the market. With programs like the Biotechnology Industry Research Assistance Council (BIRAC) and the Biotechnology Vision 2025, the government has been aggressively advancing biotechnology with the goal of making India a biotechnology leader on a worldwide scale. Additionally, since India prioritises food security and sustainable agricultural methods, the development of agro-biotechnology for enhancing crop yields and insect resistance is becoming more and more significant. Opportunities in the Indian nanobiotechnology market are growing, especially in the areas of biosensors and drug delivery systems. There is plenty of opportunity to investigate novel uses of nanotechnology in diagnostics and treatments due to the expanding healthcare industry and rising R&D expenditures. Furthermore, in order to improve drug absorption and produce more potent therapies, the Indian pharmaceutical industry is quickly implementing nano-based technology. Collaborations between Indian academic institutions and industry actors have increased recently, according to trends. These collaborations are crucial for turning scientific findings into useful applications, especially in the fields of agriculture and healthcare. Additionally, researchers are focussing on biodegradable nanomaterials to lessen their influence on the environment, as the nano-biotechnology industry places an increasing emphasis on ecologically sustainable practices. The landscape of nanobiotechnology is anticipated to change as India develops its regulatory frameworks and encourages innovation, opening the door for new discoveries and uses. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review **India Nano Biotechnology Market Drivers** **Increasing Demand for Cancer Treatment Solutions** In India, the incidence of cancer has been on a steady rise, with the Indian Council of Medical Research (ICMR) reporting that approximately 1.5 million new cases were registered in 2023, and the number is projected to increase to 1.7 million by 2025. This escalating demand for effective cancer treatment drives the growth of the India Nano Biotechnology Market, as nanobiotechnology offers innovative approaches for targeted drug delivery and personalized medicine. Leading organizations such as the Tata Memorial Centre and the All India Institute of Medical Sciences are actively involved in research and clinical trials focused on nanobiotechnology solutions for cancer treatment. The interest from these established institutions reflects the growing recognition of nanotechnology's potential in improving treatment efficacy and patient outcomes. **Government Initiatives and Funding for Biotechnology** The Indian government has made significant strides in boosting the biotechnology sector through various initiatives. The Department of Biotechnology (DBT) under the Ministry of Science and Technology has been allocating substantial funds to promote research in nanobiotechnology. For instance, the 'Biotechnology Startup Promotion Scheme' aims to foster innovation and support emerging biotech companies. As a result, the funding and policy support create a favorable environment for the growth of the India Nano Biotechnology Market, enabling startups and established companies to invest in research and development (R&D) and accelerate the commercialization of nanobiotech-based applications. **Rising Investments in Nanotechnology Research** The landscape of the India Nano Biotechnology Market is significantly influenced by increasing investments in nanotechnology research. According to the National Association of Software and Service Companies (NASSCOM), major companies and research institutions invested over USD 300 million in nanotechnology-related R&D in 2022 alone. Prominent organizations like the Indian Institute of Technology (IIT) and the Indian Institute of Science (IISc) are at the forefront of nanobiotechnology research, developing new applications in drug delivery systems and diagnostics. This influx of capital and innovation from established universities and research institutions enhances the potential of the nano biotechnology sector, contributing to market growth. **India Nano Biotechnology Market Segment Insights** **Nano Biotechnology Market Application Insights** The Application segment of the India Nano Biotechnology Market plays a crucial role in revolutionizing various sectors, reflecting significant advancements in technology and innovation. The market's focus on Pharmaceuticals highlights its pivotal importance, as nano-biotechnology enhances the development of novel drug delivery systems, improving the efficacy and safety of therapeutic agents while reducing side effects. In the realm of Medical devices, the integration of nanotechnology leads to the creation of smarter, more efficient diagnostic tools and implants that provide better patient outcomes. The emphasis on Medical research showcases how nano-biotechnology is driving innovations in diagnostics and treatment methodologies, enabling researchers to explore new avenues for combating diseases more effectively. In the Food and Agriculture sector, nanotechnology contributes to improved crop yields, enhanced nutrient delivery, and solutions for pest control, ultimately supporting food security initiatives. This diversified focus within the Application segment underscores the growing significance of the India Nano Biotechnology Market, where developments are not only addressing current challenges but also shaping the future of healthcare, agriculture, and research industries. Overall, the market exhibits a promising trajectory driven by rising investment from both public and private sectors, fostering an environment ripe for innovation and growth. Insights into this sector indicate that advancements in Nano Biotechnology are set to significantly impact the Indian economy and its global standing in scientific research and application. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review **Nano Biotechnology Market Therapeutics Insights** The Therapeutics segment of the India Nano Biotechnology Market is gaining significant attention and is poised for substantial growth, driven by advancements in nanotechnology that enhance the efficacy and delivery of medical treatments. Within this segment, Dental therapies are increasingly important as they provide innovative solutions for oral diseases, leveraging nanomaterials to improve regeneration and healing processes. Cardiac therapies harness nanotechnology for targeted drug delivery and regenerative medicine, addressing the rising incidence of cardiovascular diseases in India. Orthopedic therapies focus on using nanotechnology materials for enhanced bone repair and prosthetics, which is critical given the increasing number of orthopedic surgeries due to lifestyle-related issues. Additionally, the 'Others' segment includes various emerging applications that utilize nanotechnology in treating chronic illnesses and age-related conditions. The rise in chronic diseases, along with a growing population and aging demographic, are favorable factors contributing to the expansion of the India Nano Biotechnology Market, as stakeholders seek innovative therapeutic solutions to improve patient outcomes. With a robust Research and Development framework, India is positioned to emerge as a leader in the global market for therapeutic applications involving nanotechnology, thereby significantly influencing India Nano Biotechnology Market statistics and revenue. **India Nano Biotechnology Market Key Players and Competitive Insights** The India Nano Biotechnology Market is characterized by a rapidly evolving landscape, driven by innovations in nanotechnology and its applications across various sectors, including healthcare, agriculture, and environmental science. The competitive environment is enhanced by the presence of both established players and emerging startups dedicated to advancing nano-biotechnology solutions. These companies are focusing on the development of novel products and technologies that leverage the unique properties of nanoparticles for enhanced efficacy and efficiency. The integration of nanotechnology in biotechnology is fostering advancements in drug delivery systems, diagnostics, and therapeutic applications, leading to a robust ecosystem where companies continuously strive to enhance their market position through strategic collaborations and research initiatives. Sartorius has carved a significant niche within the India Nano Biotechnology Market, focusing on bioprocessing and laboratory solutions. The company's strengths lie in its extensive portfolio that includes advanced process technology and effective bioprocessing solutions, which are essential for the development and manufacture of biopharmaceuticals. Sartorius has established a strong presence through its commitment to innovation and quality, which resonates strongly with customers in the biotechnology sector. The company's focus on providing customizable solutions has cemented its reputation, enabling it to cater effectively to various segments within the Indian nano-biotechnology landscape. Furthermore, Sartorius emphasizes research and development to ensure it stays at the forefront of technological advancements, making it a vital player in the industry. Intas Pharmaceuticals has positioned itself as a key player in the India Nano Biotechnology Market, focusing on formulations that leverage nano-biotechnology to enhance therapeutic delivery systems. The company is renowned for its robust pipeline of biosimilars and novel drug formulations aimed at providing better treatment options for various medical conditions. Intas Pharmaceuticals has established a comprehensive market presence, driven by its commitment to quality, innovation, and customer-centric solutions. The company’s strengths include its significant investment in research and development, which has enabled it to introduce several key products that utilize nanotechnology to improve drug stability and delivery. Moreover, Intas Pharmaceuticals has pursued strategic mergers and acquisitions to bolster its capabilities and expand its market footprint, which further enhances its competitive edge in the Indian nano-biotechnology sector. **Key Companies in the India Nano Biotechnology Market Include:** - Sartorius - Intas Pharmaceuticals - Zydus Cadila - Jubilant Life Sciences - Agilent Technologies - Dr Reddy's Laboratories - AstraZeneca India - Merck Group - IIL - Thermo Fisher Scientific - Torrent Pharmaceuticals - Bharat Biotech - Wockhardt - Lupin Pharmaceuticals - Biocon **India Nano Biotechnology****Market****Developments** The India Nano Biotechnology Market is witnessing significant growth with noted developments in recent months. In October 2023, Biocon announced advancements in its biopharmaceutical offerings focused on nanoparticle technology aimed at oncology treatments. In September 2023, Sartorius expanded its product portfolio catering to nano-scale bioprocessing, enhancing its manufacturing capabilities in the region. Additionally, Zydus Cadila reported progress in developing biosimilars utilizing nanotechnology, contributing to the range of affordable healthcare options. Moreover, Lupin Pharmaceuticals and Bharat Biotech are investing in Research and Development to innovate in vaccine delivery systems incorporating nanoparticle technologies. AstraZeneca India formed collaborations in August 2023 to advance ongoing research initiatives in nano-delivery systems that improve therapeutic efficacy. When it comes to mergers and acquisitions, Dr. Reddy's Laboratories successfully integrated a tech-based firm in July 2023, enhancing its nanotechnology capabilities. The market continues to expand, driven by rising investments from both domestic and international players, improving healthcare solutions, thereby impacting patient outcomes positively across India. **India Nano Biotechnology Market Segmentation Insights** **Nano Biotechnology Market Application Outlook** - Pharmaceuticals - Medical devices - Medical research - Food and Agriculture **Nano Biotechnology Market Therapeutics Outlook** - Dental therapies - Cardiac therapies - Orthopedic therapies - Others ## Market Drivers ### Emergence of Personalized Medicine The shift towards personalized medicine significantly influences the nano biotechnology market in India. As healthcare becomes more patient-centric, there is a growing emphasis on tailoring treatments to individual genetic profiles. Nano biotechnology plays a pivotal role in this transformation by enabling the development of customized drug formulations and diagnostic tools. The market for personalized medicine in India is anticipated to grow at a CAGR of 15% over the next five years, reflecting the increasing integration of nano technologies in healthcare. This trend suggests that the nano biotechnology market will continue to expand as it aligns with the broader movement towards personalized healthcare solutions. ### Government Support and Policy Framework The Indian government is actively promoting the nano biotechnology market through supportive policies and initiatives. Programs aimed at enhancing biotechnology infrastructure and fostering collaboration between academia and industry are being implemented. The National Biotechnology Development Strategy outlines a roadmap for the growth of the sector, with specific focus on nano biotechnology applications. This strategic support is expected to create a conducive environment for innovation and investment, potentially leading to a market growth rate of 20% by 2027. Such government backing is crucial for establishing India as a key player in the global nano biotechnology landscape. ### Increasing Demand for Targeted Therapies The demand for targeted therapies in India is propelling the growth of the nano biotechnology market. With a rising prevalence of chronic diseases, including cancer and diabetes, there is a pressing need for more effective treatment options. Nano biotechnology offers the potential for targeted drug delivery systems that can minimize side effects and enhance therapeutic efficacy. According to recent estimates, The market for targeted therapies in India was projected to reach $10 billion by 2026, indicating a robust growth trajectory. This increasing demand is likely to stimulate further advancements in nano biotechnology, as companies strive to develop innovative solutions that cater to the specific needs of patients. ### Rising Investment in Research and Development The nano biotechnology market in India is experiencing a surge in investment, particularly in research and development (R&D). Government initiatives, such as the Biotechnology Industry Research Assistance Council (BIRAC), are providing funding and support to startups and established companies. This financial backing is crucial for fostering innovation in nano biotechnology applications, including drug delivery and diagnostics. In 2025, the Indian government allocated approximately $1 billion to enhance biotechnology research, which is expected to significantly impact the market. As a result, the growth of R&D activities is likely to lead to the development of novel nano-based solutions, thereby driving the overall market forward. ### Growing Awareness of Environmental Sustainability There is a rising awareness of environmental sustainability in India, which is positively impacting the nano biotechnology market. As industries seek eco-friendly solutions, nano biotechnology offers innovative approaches to waste management, pollution control, and sustainable agriculture. The market for green technologies is projected to reach $5 billion by 2028, driven by the adoption of nano-based solutions that minimize environmental impact. This growing emphasis on sustainability is likely to encourage investments in nano biotechnology, as companies strive to develop products that align with environmental goals. Consequently, the market is expected to witness substantial growth as it addresses both economic and ecological challenges. ## Future Outlook The [Nano Biotechnology Market](https://www.marketresearchfuture.com/reports/nano-biotechnology-market-10593) is projected to grow at a 9.6% CAGR from 2025 to 2035, driven by advancements in drug delivery, diagnostics, and agricultural applications. **New opportunities:** - Development of targeted drug delivery systems utilizing nanoparticles. - Expansion of nano-enabled diagnostic tools for early disease detection. - Investment in sustainable agricultural solutions through nano fertilizers. By 2035, the nano biotechnology market is expected to achieve substantial growth and innovation. ## Segment Insights ### By Application: Pharmaceuticals (Largest) vs. Medical Devices (Fastest-Growing) The Application segment of the India nano biotechnology market demonstrates a varied distribution of market share among its constituents. Pharmaceuticals hold a significant portion of the market, owing to their essential role in drug development and therapeutic innovations. Medical Devices are also gaining traction, showing considerable interest from investors and manufacturers as they integrate nanotechnology for enhanced performance and efficacy. Growth trends within this segment are driven by the increasing demand for advanced pharmaceuticals and innovative medical devices. The rise in healthcare expenditures and the growing focus on personalized medicine further bolster the market. Additionally, advancements in nanotechnology are enabling the development of novel applications in food and agriculture, presenting emerging opportunities for stakeholders in the India nano biotechnology market. Pharmaceuticals (Dominant) vs. Medical Devices (Emerging) Pharmaceuticals remain the dominant force in the Application segment, characterized by strong R&D investments and a robust pipeline of nanomedicines. This dominance is attributed to the sector's ability to deliver targeted therapies and improve the pharmacokinetic profiles of drugs, leading to better patient outcomes. Conversely, Medical Devices are emerging as a significant player in this segment, with innovations like nanosensors and drug delivery systems reshaping traditional approaches. Their rapid growth is aided by technological advancements and a favorable regulatory environment, driving manufacturers to explore the potential of nanotechnology for creating next-generation medical solutions. ### By Therapeutics: Dental Therapies (Largest) vs. Cardiac Therapies (Fastest-Growing) The India nano biotechnology market showcases varied market share distribution among therapeutic segments. Dental therapies dominate the landscape, driven by an increasing emphasis on oral health and advancements in treatment methodologies. They capture the largest share due to rising awareness and accessibility to nano-based dental products. In contrast, cardiac therapies, while currently lower in total market share, are rapidly gaining ground, spurred by innovations that enhance treatment efficacy and patient outcomes. Growth trends in the therapeutics segment indicate a robust future, especially for cardiac therapies. The increasing prevalence of cardiovascular diseases drives the expansion of this segment. Additionally, the demand for minimally invasive treatment options contributes to this growth. Furthermore, technological advancements in nano formulations are expected to provide better therapeutic options, thus encouraging investments and research in cardiac therapies, leading to their status as the fastest-growing area within the market. Dental Therapies (Dominant) vs. Cardiac Therapies (Emerging) Dental therapies represent the dominant segment in the India nano biotechnology market, attributed to the rising need for oral care and the clinical effectiveness of nano-enhanced treatments. These therapies, which include nano-particles for cavity treatment and gum disease management, have seen significant acceptance in dental practice. Meanwhile, cardiac therapies are emerging as a key focus area, with innovators leveraging nanotechnology to deliver more effective cardiovascular treatments. This segment is characterized by its focus on breakthrough applications such as drug delivery systems that work at the cellular level, aiming to significantly improve patient care in a field that is critical for public health. ## Competitive Benchmarking The nano biotechnology market in India is characterized by a dynamic competitive landscape, driven by rapid advancements in technology and increasing investments in research and development. Key players are focusing on innovation and strategic partnerships to enhance their market presence. Companies such as Amgen Inc (US), Bayer AG (DE), and Thermo Fisher Scientific Inc (US) are at the forefront, leveraging their extensive resources to develop cutting-edge solutions. Amgen Inc (US) emphasizes biopharmaceuticals, while Bayer AG (DE) is integrating nano solutions into agricultural biotechnology, and Thermo Fisher Scientific Inc (US) is enhancing its product offerings through digital transformation and automation, collectively shaping a competitive environment that prioritizes technological advancement and market responsiveness.In terms of business tactics, companies are increasingly localizing manufacturing to reduce costs and optimize supply chains. The market structure appears moderately fragmented, with several players vying for dominance. This fragmentation allows for a diverse range of products and services, but also intensifies competition among key players. The collective influence of these companies is significant, as they drive innovation and set industry standards, thereby shaping the overall market dynamics. In October Bayer AG (DE) announced a strategic partnership with a leading Indian agricultural firm to develop nano-enabled crop protection solutions. This collaboration is poised to enhance Bayer's product portfolio and expand its reach in the Indian market, reflecting a growing trend towards localized innovation in response to regional agricultural challenges. The strategic importance of this partnership lies in its potential to improve crop yields and sustainability, aligning with global demands for more efficient agricultural practices. In September Thermo Fisher Scientific Inc (US) launched a new line of nano-based diagnostic tools aimed at enhancing precision medicine. This initiative underscores the company's commitment to innovation and positions it as a leader in the rapidly evolving diagnostics sector. The introduction of these tools is likely to facilitate more accurate disease detection and monitoring, thereby improving patient outcomes and reinforcing Thermo Fisher's competitive edge in the market. In August Amgen Inc (US) expanded its research facilities in India, focusing on the development of nano-biotechnology applications in therapeutics. This expansion not only signifies Amgen's long-term commitment to the Indian market but also highlights the increasing importance of localized research in driving innovation. By investing in local capabilities, Amgen aims to accelerate the development of novel therapies, which could significantly enhance its competitive positioning in the biopharmaceutical sector. As of November current competitive trends in the nano biotechnology market include a pronounced shift towards digitalization, sustainability, and the integration of artificial intelligence. Strategic alliances are increasingly shaping the landscape, enabling companies to pool resources and expertise to drive innovation. The competitive differentiation is likely to evolve from traditional price-based competition to a focus on technological advancements, innovation, and supply chain reliability, suggesting a future where companies that prioritize these elements will thrive. ## Recent News & Developments The India Nano Biotechnology Market is witnessing significant growth with noted developments in recent months. In October 2023, Biocon announced advancements in its biopharmaceutical offerings focused on nanoparticle technology aimed at oncology treatments. In September 2023, Sartorius expanded its product portfolio catering to nano-scale bioprocessing, enhancing its manufacturing capabilities in the region. Additionally, Zydus Cadila reported progress in developing biosimilars utilizing nanotechnology, contributing to the range of affordable healthcare options. Moreover, Lupin Pharmaceuticals and Bharat Biotech are investing in Research and Development to innovate in vaccine delivery systems incorporating nanoparticle technologies. AstraZeneca India formed collaborations in August 2023 to advance ongoing research initiatives in nano-delivery systems that improve therapeutic efficacy. When it comes to mergers and acquisitions, Dr. Reddy's Laboratories successfully integrated a tech-based firm in July 2023, enhancing its nanotechnology capabilities. The market continues to expand, driven by rising investments from both domestic and international players, improving healthcare solutions, thereby impacting patient outcomes positively across India. ## Report Scope | MARKET SIZE 2024 | 244.63(USD Million) | | --- | --- | | MARKET SIZE 2025 | 268.12(USD Million) | | MARKET SIZE 2035 | 670.68(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 9.6% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Amgen Inc (US), Bayer AG (DE), Thermo Fisher Scientific Inc (US), Merck KGaA (DE), Novartis AG (CH), Pfizer Inc (US), Roche Holding AG (CH), Johnson & Johnson (US), GSK plc (GB) | | Segments Covered | Application, Therapeutics | | Key Market Opportunities | Advancements in targeted drug delivery systems enhance therapeutic efficacy in the nano biotechnology market. | | Key Market Dynamics | Rising investment in Research and Development drives innovation in the nano biotechnology market, enhancing competitive dynamics. | | Countries Covered | India | ## Frequently Asked Questions **Q: What is the current valuation of the India nano biotechnology market?** A: The market valuation was $244.63 Million in 2024. **Q: What is the projected market size for the India nano biotechnology market by 2035?** A: The projected valuation for 2035 is $670.68 Million. **Q: What is the expected CAGR for the India nano biotechnology market during the forecast period 2025 - 2035?** A: The expected CAGR is 9.6%. **Q: Which segments are included in the India nano biotechnology market?** A: Key segments include Pharmaceuticals, Medical Devices, Medical Research, and Food and Agriculture. **Q: What were the valuations for the Pharmaceuticals segment in 2024?** A: The Pharmaceuticals segment had valuations ranging from $40.93 Million to $112.0 Million. **Q: How does the Medical Devices segment perform in the India nano biotechnology market?** A: The Medical Devices segment had valuations between $30.0 Million and $80.0 Million. **Q: What is the valuation range for the Food and Agriculture segment?** A: The Food and Agriculture segment had valuations from $123.7 Million to $348.68 Million. **Q: What are the key therapeutic areas in the India nano biotechnology market?** A: Key therapeutic areas include Dental Therapies, Cardiac Therapies, Orthopedic Therapies, and Others. **Q: What were the valuations for Cardiac Therapies in 2024?** A: Cardiac Therapies had valuations ranging from $50.0 Million to $150.0 Million. **Q: Who are the key players in the India nano biotechnology market?** A: Key players include Amgen Inc, Bayer AG, Thermo Fisher Scientific Inc, Merck KGaA, Novartis AG, Pfizer Inc, Roche Holding AG, Johnson & Johnson, and GSK plc. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/india-nano-biotechnology-market-51846*